Variability in Sleep Duration May Affect Blood Glucose Control in Diabetes
Sleep may be an important modifiable factor in disease management in patients with type 2 diabetes, especially variation in sleep duration.
Sleep may be an important modifiable factor in disease management in patients with type 2 diabetes, especially variation in sleep duration.
Evidence to date suggests that the risk for all-cause dementia is 40% to 60% higher in patients with type 1 or type 2 diabetes.
The magnitude of the association of diabetes with stroke risk varies by age, race, and sex.
Perineural injection of platelet-rich plasma may improve pain and numbness associated with diabetic peripheral neuropathy, and enhance peripheral nerve function.
Hyperglycemia on admission is associated with worse clinical outcomes in patients with and without diabetes following intravenous thrombolysis for acute ischemic stroke.
Researchers found a substantial cohort of adults with diabetic peripheral neuropathy in the United States with high financial and social costs.
Group acupuncture may alleviate pain and improve quality of life in patients with painful diabetic neuropathy.
Diabetes, poor glycemic control, and longer diabetes duration are associated with worse cognitive outcomes in older adults.
Patients with midlife type 2 diabetes have a significantly increased risk for cerebral infarction and occlusion of cerebral arteries later in life.
Mean fasting plasma glucose in the high-normal range during early adolescence may be associated with poorer brain health in midlife.